A New Frontier in the Co-Management of Thyroid Eye Disease

About A New Frontier in the Co-Management of Thyroid Eye Disease

Thyroid eye disease, also known as Graves’ orbitopathy, is a potentially serious, progressive autoimmune disease that most often occurs in people with hyperthyroidism, ie, Graves’ disease. Kimberley Cockerham, MD, FACS, moderates this series of six, paired conversations between endocrinologist Terry J. Smith, MD, and eye specialists Wendy W. Lee, MD, and Raymond Douglas, MD, PhD, to explore current and emerging treatment options for thyroid eye disease. In these conversations, faculty review the current understanding of the burden and pathophysiology of thyroid eye disease—including treatment

Publisher

Annenberg Center for Health Sciences

Category

health & fitness

Language

en

Explicit

No

First episode

24 Sept 2021

Latest episode

24 Sept 2021

Latest episodes

6 episodes in the feed.

1. 

   24 Sept 2021

   Radiation, Surgery

   The role for external beam radiation and orbital decompression in treating patients with thyroid eye disease Other surgical options for treating patients with thyroid eye disease

2. 

   24 Sept 2021

   Clinical Trials Experience

   Clinical data supporting the approval of teprotumumab How efficacy was assessed in the teprotumumab trials Emerging therapies for patients with thyroid eye disease

3. 

   24 Sept 2021

   Treatment

   The role of intervention in patient management Therapy selection for patients with thyroid eye disease Evaluating treatment responses

4. 

   24 Sept 2021

   Patient Evaluation

   How patients present with thyroid eye disease Differential diagnosis for thyroid eye disease How endocrinologists and ophthalmologists approach patient evaluation

5. 

   24 Sept 2021

   Pathophysiology

   Causes of thyroid eye disease Known risk factors in thyroid eye disease

6. 

   24 Sept 2021

   Burden of Disease

   Incidence and prevalence of thyroid eye disease The clinical implications of thyroid eye disease for patients The traditional course of thyroid eye disease

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

5.0 / 5

1 ratings